Author Question: A nurse caring for a client with atrial fibrillation who is started on digoxin therapy is required ... (Read 69 times)

cagreen833 · **on:** Jul 23, 2018

A nurse caring for a client with atrial fibrillation who is started on digoxin therapy is required to monitor plasma drug levels. The nurse would report which level to the primary health care provider?

A) 1.6 ng/mL
B) 1.8 ng/mL
C) 2.0 ng/mL
D) 2.2 ng/mL

Question 2

When caring for a client who has been digitalized for his heart failure, the nurse observes that the client is experiencing bradycardia.

Which of the following would the nurse expect the primary health care provider to prescribe for the client's bradycardia?

A) Atropine
B) Cholestyramine
C) Furosemide
D) Milrinone

sarajane1989 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Ans: D
Feedback:
A plasma digoxin level of more than 2 ng/mL would require the nurse to report to the primary health care provider; therefore, plasma digitalis levels of 2.2 ng/mL indicate digoxin toxicity. The therapeutic levels range from 0.5 to 2 ng/mL.

Answer to Question 2

Ans: A
Feedback:
Atropine should be administered to clients who develop bradycardia. Bradycardia may be seen in digitalis toxicity. Milrinone is a miscellaneous inotropic used in heart failure. Furosemide is a loop diuretic that can be used as part of the drug therapy regimen for heart failure. Cholestyramine is used to lower blood cholesterol levels. Milrinone, furosemide, and cholestyramine are not used in the treatment of bradycardia.